会社概要
- 正式社名: Chengdu Climb Pharmaceutical Technology Co., Ltd.
- 国際名称: 成都克莱蒙医药科技有限公司 (Chengdu Climb Pharmaceutical Technology Co., Ltd.), Chengdu, Sichuan, China
- ブランド名 / 商号: Climb
- 登録国: China
- 住所: Room 909-911, Building C1, No. 88 Keyuan South Road, Tianfu Life Science & Technology Park, Gaoxin District, Chengdu 610041, Sichuan, China • Sichuan
- 設立年: 2013
説明:
Chengdu Climb Pharmaceutical Technology Co., Ltd., established in 2013, manufactures and trades active pharmaceutical ingredients and pharmaceutical intermediates and fine chemicals for markets worldwide. The company offers contract manufacturing services and is recognized for its international approvals, experienced R&D staff, production capacity and quality service.
事業活動
原薬(API)
サプライヤー原薬メーカー製造業者
完成医薬品(製剤)
製造業者
受託・アウトソーシングサービス
サービスプロバイダー
販売市場
- East Asia: China, Democratic People's Republic of Korea, Republic of Korea, Japan
- Western Asia: Cyprus
- Northern Europe: Denmark, Finland, Iceland, Ireland, Norway, Sweden, United Kingdom
- Southern Europe: Andorra, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain, Vatican City
- Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland
主要製品/サービス
- 原薬(API): Palbociclib, Etoricoxib, Active Pharmaceutical Ingredients, Brivaracetam, Avibactam Sodium, Apixaban, Vinpocetine, Parecoxib Sodium, Rupatadine fumarate, Macitentan, Moxifloxacin hydrochloride, Anacetrapib, Anamorelin, AZD9291, Cinacalcet HCl, Desvenlafaxine succinate, Macimorelin Acetate, Parecoxib Sodium cas:197502-82-2, Phenylethyl caffeate, ROLAPITANT, Tirofiban hydrochloride monohydrate
- 完成医薬品(製剤): Lactulose oral solution, Finished antibiotic medicines
- 医薬用化学品: Active Pharmaceutical Ingredients, Pharmaceutical Intermediates, (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol, 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one, (S,S)-2,8-Diazabicyclo[4,3,0]nonane, Vincamine, 1-(6-Methylpyridin-3-yl)-2-[4(methylsulfonyl)phenyl]ethanone, 4-Methylsulfonyl phenyl acetic acid, 1-(6-methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone, 10,10-dimethylanthrone, 2-Chloro-1,3-bis(dimenthylamino)trimethinium hexafluorophosphate, 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3d] pyrimidine-6-carboxamide, 2'-(Chloromethyl)-4-fluoro-5-isopropyl-2-Methoxy-4'- (trifluoroMethyl)-1,1'-biphenyl, 2-(trifluoromethyl)pyridin -4-amine, 2,4-dichloro-6-(6-(trifluoromethyl)pyridin -2-yl)-1,3,5-triazine, (2S,5R)- 5-(benzyloxyamino)piperidine -2-carboxamide, (2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate, (2s,5r)-5-((phenylmethoxy)amino) -2-piperidinecarboxylic acid ethyl ester ethanedioate, (2S,5R)-benzyl 5-(benzyloxyamino)piperidine -2-carboxylate, 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone, 3-(Chloromethyl)-5-methylpyridine, (3R)-3-(Phenylmethyl)-3-piperidinecarboxylic acid trimethylhydrazide, 4-(4-Chlorobutyl)pyridine hydrochloride, 4-[6-[(6-Bromo-8-cyclopentyl-7,8-dihydro-5-methyl-7- oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridin, 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate, 4'-FLUORO-2'-METHOXY-5'-ISOPROPYL-4-TRIFLUOROMETHYL-1,1'-BIPHENYL-2-METHANOL, 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo- 1H-pyrazolo[3,4-c]pyridine-3-carboxy, (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl] -4-methyl-1,3-oxazolidin- 2-one, 5-(4-Bromophenyl)-4,6-dichloropyrimidine, 5-Bromo-2-chloropyrimidine, 5-hydroxy-4-propyl-2(5H)-furanone, 5-Methyl-3,4-diphenyl- Isoxazole, 6-Benzofurancarboxylic acid, 6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride, Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate, Methyl-6-methylnicotinate, methyl 6-(trifluoromethyl)picolinate, N-[2-Chloro-3-bis(dimethylamino)trimethinium, N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine, N-Butylsulfonyl-L-tyrosine, N-Propyl-sulfamide potassium salt, N-Propyl-sulfamide sodium salt, N-Propylsulfamide, N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze, (R)-1-(1-(bromomethoxy)ethyl) -3,5-bis(trifluoromethy l)benzene, (R)-Dihydro-4-propyl-2(3H)-furanone, Rucaparib, Tabersonine, VALDECOXIB
- ATC分類(解剖治療化学分類): Desloratadine
当社の製品・サービス
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Pharma Chemicals
![(2S,5R)-5-[(benzyloxy)amino]piperidine -2-carboxylic acid benzyl ester ethanedioate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F2s5r-5-benzyloxyaminopiperidine--2-carbo-78005.jpg&w=640&q=75)
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
![Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fethyl-chloro4-methoxyphenylhydrazonoacet-78013.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
![N1-[2-(diMethylaMino)ethyl] -5-Methoxy-N1-Methyl-N4-[4-(1- Methyl-1H-indol-3-yl)-2-pyriMidinyl]benze](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2Fn1-2-dimethylaminoethyl--5-methoxy-n1-me-78016.jpg&w=640&q=75)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
認証
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す